Based on these data showing the potential importance of CD4+ T cells combined with Th2-related antitumor cytokine interactions in tumor clearance, we investigated how these diverse mechanisms interact with periodically pulsed therapies to dictate the antitumor function in this setting. The gene discussed is CD4; the disease is neoplasm.